Drug Combo for Common Neuroendocrine Tumor: A New Standard? ...Middle East

Medscape - News
Drug Combo for Common Neuroendocrine Tumor: A New Standard?
Adding lanreotide to everolimus significantly prolonged progression-free survival compared with everolimus alone in patients with gastroenteropancreatic neuroendocrine tumors, a phase 3 trial found. Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( Drug Combo for Common Neuroendocrine Tumor: A New Standard? )

Also on site :